Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

mRNA Vaccination to Boost Antibodies Against SARS-CoV-2 in Recipients of Inactivated Vaccines (the "mBoost" Study)

NCT05057182 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT05057182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05057182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
mRNA Vaccination to Boost Antibodies Against SARS-CoV-2 in Recipients of Inactivated Vaccines (the "mBoost" Study)
Lead sponsor
The University of Hong Kong
Phase
Phase 4
Overall status
Completed
Start date
October 18, 2021
Completion date
December 31, 2024
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid 19 vaccine